PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 15246363-7 2004 Binding in SERT-rich brain regions was reduced significantly by pretreatment with either the cold compound 8 or with the selective serotonin reuptake inhibitor (SSRI) citalopram, but not by the selective norepinephrine reuptake inhibitor nisoxetine, thus underlining its in vivo binding selectivity and specificity for SERT. Citalopram 167-177 solute carrier family 6 member 4 Rattus norvegicus 11-15 15659538-7 2005 SERT inhibitors citalopram and fluoxetine inhibited responses to 5-HT in SD vessels. Citalopram 16-26 solute carrier family 6 member 4 Rattus norvegicus 0-4 15607480-7 2004 Moreover, such binding in SERT-rich brain regions is reduced significantly by pretreatment with either citalopram or the cold compound itself, but not by nisoxetine or GBR 12935, thus demonstrating that [(11)C]AFE binding in the rat brain is saturable, specific and selective for the SERT. Citalopram 103-113 solute carrier family 6 member 4 Rattus norvegicus 26-30 15607480-7 2004 Moreover, such binding in SERT-rich brain regions is reduced significantly by pretreatment with either citalopram or the cold compound itself, but not by nisoxetine or GBR 12935, thus demonstrating that [(11)C]AFE binding in the rat brain is saturable, specific and selective for the SERT. Citalopram 103-113 solute carrier family 6 member 4 Rattus norvegicus 284-288 15607480-10 2004 Pretreatment of the baboon with citalopram (4 mg/kg) 20 min before radioactivity injection reduced the binding of [(11)C]AFE in all SERT-containing brain regions to the level in the cerebellum. Citalopram 32-42 solute carrier family 6 member 4 Rattus norvegicus 132-136 15246363-7 2004 Binding in SERT-rich brain regions was reduced significantly by pretreatment with either the cold compound 8 or with the selective serotonin reuptake inhibitor (SSRI) citalopram, but not by the selective norepinephrine reuptake inhibitor nisoxetine, thus underlining its in vivo binding selectivity and specificity for SERT. Citalopram 167-177 solute carrier family 6 member 4 Rattus norvegicus 319-323 15246363-10 2004 Pretreatment of the baboon with citalopram (4 mg/kg) significantly reduced the specific binding of [11C]AFA in all SERT-containing brain regions. Citalopram 32-42 solute carrier family 6 member 4 Rattus norvegicus 115-119 15219271-8 2004 Furthermore, binding of [(11)C]AFM in SERT-rich regions was blocked by the cold compound AFM and the selective serotonin reuptake inhibitor citalopram but not by the selective norepinephrine reuptake inhibitor nisoxetine or the selective dopamine reuptake inhibitor GBR 12935. Citalopram 140-150 solute carrier family 6 member 4 Rattus norvegicus 38-42 15219271-11 2004 Pretreatment of the baboons with citalopram (4 and 6 mg/kg, intravenously) reduced regional brain distribution volumes to low and homogeneous levels, thus underlining the binding specificity of [(11)C]AFM for SERT in vivo. Citalopram 33-43 solute carrier family 6 member 4 Rattus norvegicus 209-213 14971892-10 2004 Radioactivity in the regions of high SERT density of monkey brain was displaceable with citalopram except in the putamen and caudate. Citalopram 88-98 solute carrier family 6 member 4 Rattus norvegicus 37-41 12876551-13 2003 The reason for these differences between the two enantiomers might concern the secondary molecular targets at which citalopram acts, but with affinities at least two orders of magnitude less than for the serotonin transporter. Citalopram 116-126 solute carrier family 6 member 4 Rattus norvegicus 204-225 14605793-2 2003 The effects of the SERT inhibitor, citalopram (100 nM), on contractions to 5-HT were determined in isolated ring preparations of pulmonary artery (intralobar and main) and compared with data obtained in systemic arteries. Citalopram 35-45 solute carrier family 6 member 4 Rattus norvegicus 19-23 12719960-6 2003 RESULTS: Escitalopram inhibited 5-HTT functions approximately 2 times more potently than citalopram and at least 40 times more potently than R-citalopram. Citalopram 9-21 solute carrier family 6 member 4 Rattus norvegicus 32-37 12719960-6 2003 RESULTS: Escitalopram inhibited 5-HTT functions approximately 2 times more potently than citalopram and at least 40 times more potently than R-citalopram. Citalopram 11-21 solute carrier family 6 member 4 Rattus norvegicus 32-37 14515339-16 2003 SERT inhibitors (sertraline, paroxetine, citalopram, and fluoxetine) also increased PKC activity. Citalopram 41-51 solute carrier family 6 member 4 Rattus norvegicus 0-4 12957338-4 2003 The binding of [18F]FMe-McN was reduced by citalopram, a highly selective inhibitor for SERT. Citalopram 43-53 solute carrier family 6 member 4 Rattus norvegicus 88-92 12957338-13 2003 Furthermore, the distribution volume of [18F]FMe-McN calculated from the PET data in various regions of the porcine brain is highly correlated with the SERT density as determined by in vitro autoradiography with [3H]citalopram. Citalopram 216-226 solute carrier family 6 member 4 Rattus norvegicus 152-156 14511335-8 2003 Block of the serotonin transporter (SERT) with citalopram slowed the time course and reduced overall 5-HT release by MDMA. Citalopram 47-57 solute carrier family 6 member 4 Rattus norvegicus 13-34 14511335-8 2003 Block of the serotonin transporter (SERT) with citalopram slowed the time course and reduced overall 5-HT release by MDMA. Citalopram 47-57 solute carrier family 6 member 4 Rattus norvegicus 36-40 12381454-6 2002 Moreover, such binding in SERT-rich regions of the brain are blocked by pretreatment with either the selective serotonin reuptake inhibitor (SSRI) citalopram and by the cold compound itself, demonstrating that [11C]DAPA binding in the rat brain is saturable and specific to SERT. Citalopram 147-157 solute carrier family 6 member 4 Rattus norvegicus 26-30 12381454-8 2002 Pretreatment of the baboon with citalopram 10 min before radioactivity injection blocked the binding of [11C]DAPA in all brain regions that contain SERT. Citalopram 32-42 solute carrier family 6 member 4 Rattus norvegicus 148-152 11709064-4 2001 Long-term exposure of SERT to a selective 5-HT-re-uptake inhibitor, citalopram, resulted in the down-regulation of the expression level. Citalopram 68-78 solute carrier family 6 member 4 Rattus norvegicus 22-26 11961053-6 2002 The compounds were significantly less potent in displacing [(3)H]citalopram binding from the serotonin transporter. Citalopram 65-75 solute carrier family 6 member 4 Rattus norvegicus 93-114 10693966-3 2000 5-HT reuptake blockers (e.g., imipramine, citalopram) also caused an enhancement of [3H]5-HT efflux, reaching about half the maximal effect of the rSERT substrates. Citalopram 42-52 solute carrier family 6 member 4 Rattus norvegicus 147-152 11062247-2 2001 Specific binding of RTI-233 to the rat serotonin transporter, purified from Sf-9 insect cells, was demonstrated by the competitive inhibition of fluorescence using excess serotonin, citalopram, or RTI-55 (2beta-carbomethoxy-3beta-(4-iodophenyl)tropane). Citalopram 182-192 solute carrier family 6 member 4 Rattus norvegicus 39-60 9603221-2 1998 Here, we show that both the tricyclic antidepressant imipramine and the nontricyclic antidepressant citalopram competitively inhibit 5-HT transport mediated by the recombinant rat 5-HT transporter SERT1. Citalopram 100-110 solute carrier family 6 member 4 Rattus norvegicus 180-196 10546982-4 1999 Citalopram protected against the RTI-76-induced inhibition of SERT binding. Citalopram 0-10 solute carrier family 6 member 4 Rattus norvegicus 62-66 10063489-2 1999 Indicating that the effect of mCPP was caused by a reversal of the serotonin transporter, it was antagonized by pretreatment with the serotonin re-uptake inhibitor citalopram (10 mg/kg) but was unaffected by local administration of the sodium channel blocker tetrodotoxin (TTX; 1 microns). Citalopram 164-174 solute carrier family 6 member 4 Rattus norvegicus 67-88 9843724-4 1998 Drug competition studies with various monoamine uptake inhibitors gave rise to complex multiphasic displacement curves, although the results obtained with the selective 5-HT uptake inhibitor citalopram suggest that the 5-HT transporter is an important component of placental high-affinity [125I]RTI-55 binding. Citalopram 191-201 solute carrier family 6 member 4 Rattus norvegicus 219-235 9602106-2 1998 [3H]citalopram binding, reflecting the presence of 5-HT transporter on thalamocortical fibers, produced a clearcut barrel pattern from P4 to P16 (peak at P8), and decreased to a dispersed, low density in the adult. Citalopram 4-14 solute carrier family 6 member 4 Rattus norvegicus 51-67 9283827-6 1997 Tissue 5-HT recovery was dose-dependently inhibited by the concurrent perfusion of citalopram, fluoxetine and paroxetine, showing that it essentially measured uptake through the high-affinity 5-HT transporter. Citalopram 83-93 solute carrier family 6 member 4 Rattus norvegicus 192-208 9228199-4 1997 The rate constant for efflux of 3H-5-HT increased by 81% when Na+ ions were removed from the perfusion solution; increased gradually when a selective 5-HT transporter inhibitor, 200 nM citalopram, was added to the perfusion solution for the final 6 min of efflux; and increased markedly and rapidly when substrates of the 5-HT transporter, tryptamine (18 microM) and 7-methyltryptamine (12 microM), were added for the final 6 min of efflux. Citalopram 185-195 solute carrier family 6 member 4 Rattus norvegicus 150-166 9228199-4 1997 The rate constant for efflux of 3H-5-HT increased by 81% when Na+ ions were removed from the perfusion solution; increased gradually when a selective 5-HT transporter inhibitor, 200 nM citalopram, was added to the perfusion solution for the final 6 min of efflux; and increased markedly and rapidly when substrates of the 5-HT transporter, tryptamine (18 microM) and 7-methyltryptamine (12 microM), were added for the final 6 min of efflux. Citalopram 185-195 solute carrier family 6 member 4 Rattus norvegicus 322-338 8978719-6 1997 In contrast, exposure of cells to the serotonin transporter-selective drug citalopram, or the NET substrate norepinephrine, had no effects on the binding of [3H]nisoxetine to NETs. Citalopram 75-85 solute carrier family 6 member 4 Rattus norvegicus 38-59 9225308-1 1997 The NMB human neuronal cell line, transfected with a newly prepared plasmid expressing rat serotonin transporter (NMB-rSERT), shows specific [3H]5-HT uptake which is blocked by citalopram and fenfluramine (F) stereoisomers with IC50 values (1 nM. Citalopram 177-187 solute carrier family 6 member 4 Rattus norvegicus 91-112 9225308-1 1997 The NMB human neuronal cell line, transfected with a newly prepared plasmid expressing rat serotonin transporter (NMB-rSERT), shows specific [3H]5-HT uptake which is blocked by citalopram and fenfluramine (F) stereoisomers with IC50 values (1 nM. Citalopram 177-187 solute carrier family 6 member 4 Rattus norvegicus 118-123 9145769-4 1997 Moreover, despite having greater affinity for the 5-HT transporter, citalopram has an IC50 for [1H]dopamine transport into these synaptosomal preparations that is considerably greater than that of fluoxetine. Citalopram 68-78 solute carrier family 6 member 4 Rattus norvegicus 50-66 9140140-2 1997 Sertraline strongly attenuated the rate of dissociation of [3H]nisoxetine from the noradrenaline transporter, while citalopram strongly attenuated that of [3H]citalopram from the 5-HT transporter. Citalopram 116-126 solute carrier family 6 member 4 Rattus norvegicus 179-195 9101584-2 1997 The present study investigates the effects of pinoline on [3H]citalopram binding to the 5-HT transporter on rat brain. Citalopram 58-72 solute carrier family 6 member 4 Rattus norvegicus 88-104 9101584-7 1997 These results indicate that pinoline did not have any modulative influence on the activity of 5-HT transporter and it interacts competitively with citalopram on the substrate recognition site of the 5-HT transporter. Citalopram 147-157 solute carrier family 6 member 4 Rattus norvegicus 199-215 32088418-7 2020 After treatment with citalopram, a SERT-selective ligand, the uptake of [18F]7a in the hypothalamus and striatum was significantly decreased. Citalopram 21-31 solute carrier family 6 member 4 Rattus norvegicus 35-39 8813349-4 1996 reduced forebrain ([3H]citalopram binding to serotonin transporter by 62-96% whereas binding in the dorsal raphe nucleus was preserved. Citalopram 23-33 solute carrier family 6 member 4 Rattus norvegicus 45-66 32382785-8 2020 The NET-selective inhibitor nortriptyline and the SERT-selective inhibitor citalopram were generally less effective, but both drugs blocked acid-induced ICSS depression by the end of the 7-day treatment. Citalopram 75-85 solute carrier family 6 member 4 Rattus norvegicus 50-54 2147655-0 1990 Inhibitory and regulatory binding sites on the rat brain serotonin transporter: molecular weight of the [3H]paroxetine and [3H]citalopram binding proteins. Citalopram 127-137 solute carrier family 6 member 4 Rattus norvegicus 57-78 35330355-3 2022 To achieve this goal, we treated rats neonatally with the selective serotonin transporter (SERT) inhibitor escitalopram. Citalopram 107-119 solute carrier family 6 member 4 Rattus norvegicus 68-89 35330355-3 2022 To achieve this goal, we treated rats neonatally with the selective serotonin transporter (SERT) inhibitor escitalopram. Citalopram 107-119 solute carrier family 6 member 4 Rattus norvegicus 91-95 32198394-2 2020 SERT activity is modulated by antidepressants, e.g., S-citalopram and imipramine, to alleviate symptoms of depression and anxiety. Citalopram 53-65 solute carrier family 6 member 4 Rattus norvegicus 0-4 32198394-3 2020 SERT crystal structures reveal two S-citalopram binding pockets in the central binding (S1) site and the extracellular vestibule (S2 site). Citalopram 35-47 solute carrier family 6 member 4 Rattus norvegicus 0-4 30096380-2 2018 Inhibitors of SERT binding are well known as selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine, sertraline, paroxetine, and escitalopram, that are commonly prescribed antidepressants. Citalopram 141-153 solute carrier family 6 member 4 Rattus norvegicus 14-18 30290201-4 2018 Binding of [3H]nisoxetine to noradrenaline transporter (NET), [3H]GBR 12,935 to dopamine transporter (DAT) and [3H]citalopram to serotonin transporter (SERT) were analyzed by autoradiography. Citalopram 115-125 solute carrier family 6 member 4 Rattus norvegicus 129-150 30096380-12 2018 Chasing experiment with escitalopram (iv, 2 mg/kg) in a rat at 60 min after iv injection caused a noticeable reduction in the regional radioactivity and the target-to-non-target ratio, suggesting binding by [18F]1 was highly specific and reversible for SERT binding sites in the brain. Citalopram 24-36 solute carrier family 6 member 4 Rattus norvegicus 253-257 27452719-7 2016 SERT blockade with citalopram (3, 5 mg/kg) reduced LID while DAT and NET blockade with GBR-12909 (5, 10 mg/kg) and nisoxetine (5, 10 mg/kg), respectively, mildly exacerbated dyskinesia expression. Citalopram 19-29 solute carrier family 6 member 4 Rattus norvegicus 0-4 29871537-11 2018 Inhibition of serotonin transporter effectively alleviated anxiety-like behaviors following sub-chronic (15 days) treatment with systemic citalopram (10 mg/kg/day, intraperitoneally). Citalopram 138-148 solute carrier family 6 member 4 Rattus norvegicus 14-35 26628402-6 2016 Binding of [(3)H]GBR 12,935 to the dopamine transporter (DAT) and [(3)H]citalopram to SERT was analyzed autoradiographically. Citalopram 72-82 solute carrier family 6 member 4 Rattus norvegicus 86-90 27171685-1 2016 AIM: Studies using S- and R-enantiomers of the SSRI citalopram have shown that R-citalopram exerts an antagonistic effect on the efficacy of the antidepressant S-citalopram (escitalopram) through an interaction at an allosteric modulator site on the serotonin transporter (SERT). Citalopram 160-172 solute carrier family 6 member 4 Rattus norvegicus 250-271 27171685-1 2016 AIM: Studies using S- and R-enantiomers of the SSRI citalopram have shown that R-citalopram exerts an antagonistic effect on the efficacy of the antidepressant S-citalopram (escitalopram) through an interaction at an allosteric modulator site on the serotonin transporter (SERT). Citalopram 160-172 solute carrier family 6 member 4 Rattus norvegicus 273-277 27171685-1 2016 AIM: Studies using S- and R-enantiomers of the SSRI citalopram have shown that R-citalopram exerts an antagonistic effect on the efficacy of the antidepressant S-citalopram (escitalopram) through an interaction at an allosteric modulator site on the serotonin transporter (SERT). Citalopram 174-186 solute carrier family 6 member 4 Rattus norvegicus 250-271 27171685-1 2016 AIM: Studies using S- and R-enantiomers of the SSRI citalopram have shown that R-citalopram exerts an antagonistic effect on the efficacy of the antidepressant S-citalopram (escitalopram) through an interaction at an allosteric modulator site on the serotonin transporter (SERT). Citalopram 174-186 solute carrier family 6 member 4 Rattus norvegicus 273-277 27171685-7 2016 Finally, in vitro, quantification of the amount of cell surface-expressed SERT molecules revealed that R-citalopram prevented escitalopram-induced SERT internalization that was completely altered by staurosporine. Citalopram 126-138 solute carrier family 6 member 4 Rattus norvegicus 74-78 27171685-7 2016 Finally, in vitro, quantification of the amount of cell surface-expressed SERT molecules revealed that R-citalopram prevented escitalopram-induced SERT internalization that was completely altered by staurosporine. Citalopram 126-138 solute carrier family 6 member 4 Rattus norvegicus 147-151 20830689-4 2010 In the present investigation, we injected rat pups with citalopram (CTM: 5 mg/kg, 10 mg/kg, and 20 mg/kg) from postnatal Days 8-21, and examined serotonin transporter (SERT) labeling in the hippocampus, ventrobasal thalamic complex, and caudate-putamen when the subjects reached adulthood. Citalopram 56-66 solute carrier family 6 member 4 Rattus norvegicus 145-166 24618127-1 2014 The effect of blockade of either 5-hydroxytryptamine (5-HT)/serotonin transporter (SERT) with citalopram or the organic cation transporter 3 (OCT3)/plasma membrane monoamine transporter (PMAT) with decynium-22 (D-22) on spontaneous and evoked release of 5-HT in the nucleus tractus solitarius (NTS) was investigated in rat brainstem slices treated with gabazine. Citalopram 94-104 solute carrier family 6 member 4 Rattus norvegicus 83-87 23675318-2 2013 Recent studies have demonstrated altered raphe-derived 5HT transporter (SERT) immunoreactive axonal expression in several cortical target sites after brief perinatal exposure to selective 5HT reuptake inhibitors such as citalopram (CTM). Citalopram 220-230 solute carrier family 6 member 4 Rattus norvegicus 72-76 23675318-2 2013 Recent studies have demonstrated altered raphe-derived 5HT transporter (SERT) immunoreactive axonal expression in several cortical target sites after brief perinatal exposure to selective 5HT reuptake inhibitors such as citalopram (CTM). Citalopram 232-235 solute carrier family 6 member 4 Rattus norvegicus 72-76 23675318-6 2013 Our data revealed that the density of the SERT immunoreactive fibers decreased ~40% in the OB of CTM exposed male rats, but not female rats. Citalopram 97-100 solute carrier family 6 member 4 Rattus norvegicus 42-46 20696140-3 2010 In contrast, the affinity of NMC to rat brain SERT was 10-fold lower than its parent compound citalopram. Citalopram 94-104 solute carrier family 6 member 4 Rattus norvegicus 46-50 18492949-5 2008 Similar blockade of SERT binding (using [3H]-citalopram) was observed in the same area. Citalopram 45-55 solute carrier family 6 member 4 Rattus norvegicus 20-24 19419596-6 2009 Increased 5-HT transporter function under conditions of dietary restriction might contribute to the decreased effect of escitalopram. Citalopram 120-132 solute carrier family 6 member 4 Rattus norvegicus 10-26 18496518-3 2009 [(3)H]-citalopram binding (an index of 5-HT transporter (5-HTT) expression) was only slightly affected by Org 34850 alone: decreased in cortex and midbrain and increased in hippocampus. Citalopram 7-17 solute carrier family 6 member 4 Rattus norvegicus 39-55 18496518-3 2009 [(3)H]-citalopram binding (an index of 5-HT transporter (5-HTT) expression) was only slightly affected by Org 34850 alone: decreased in cortex and midbrain and increased in hippocampus. Citalopram 7-17 solute carrier family 6 member 4 Rattus norvegicus 57-62 18437564-7 2008 It was observed that the density of cortical SERT was significantly decreased with CMI (68%, P < 0.0001), FLX (67%, P < 0.0001), CIT (54%, P < 0.0001), and AMI (52%, P < 0.0001) treatment, when compared to the density of 120.7 +/- 4.0 fmol/mg protein in control rats, without altering the affinity (Kd) of [(3)H]paroxetine to the transporters. Citalopram 135-138 solute carrier family 6 member 4 Rattus norvegicus 45-49 18437564-8 2008 The density of SERT in hippocampus was also significantly decreased with FLX (65%, P < 0.0001), CMI (54%, P < 0.0001), CIT (52%, P < 0.0001) and AMI (46%, P < 0.0001) treatment, when compared to the density of 74.0 +/- 2.6 fmol/mg protein in control rats, without altering the affinity of [(3)H]paroxetine to the transporters. Citalopram 125-128 solute carrier family 6 member 4 Rattus norvegicus 15-19 18789789-19 2007 On the other hand, in the presence of the two enantiomers, R-citalopram binds to the allosteric site and decreases the escitalopram action on SERT. Citalopram 119-131 solute carrier family 6 member 4 Rattus norvegicus 142-146 17653110-6 2008 Block of serotonin transporter (SERT) with citalopram or 5-HT depletion with (+/-)-p-chlorophenylalanine pretreatment partially inhibited the ESP MDMA. Citalopram 43-53 solute carrier family 6 member 4 Rattus norvegicus 9-30 17653110-6 2008 Block of serotonin transporter (SERT) with citalopram or 5-HT depletion with (+/-)-p-chlorophenylalanine pretreatment partially inhibited the ESP MDMA. Citalopram 43-53 solute carrier family 6 member 4 Rattus norvegicus 32-36 18789789-0 2007 [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter]. Citalopram 1-13 solute carrier family 6 member 4 Rattus norvegicus 69-90 18789789-18 2007 Thus, escitalopram exerts a stabilizing effect on this association to SERT, resulting in an effective inhibition of 5-HT reuptake activity. Citalopram 6-18 solute carrier family 6 member 4 Rattus norvegicus 70-74 17885600-4 2007 The present results support the role of the allosteric modulation of the 5-HT transporter in the regulation of the recovery of 5-HT neuronal activity and long-lasting hippocampal cellular plasticity induced by escitalopram, two adaptive changes presumably associated with the antidepressant response. Citalopram 210-222 solute carrier family 6 member 4 Rattus norvegicus 73-89 17657807-8 2007 Of the seven SSRIs, [3H]-(S)-citalopram, [3H]MADAM, and [11C]DASB displayed significant specific binding to SERT in monkey cerebellum, with Bmax cortex:cerebellum ratios being 17, 3, and 4, respectively. Citalopram 25-39 solute carrier family 6 member 4 Rattus norvegicus 108-112 17307121-9 2007 The localization of [(125)I]7 in the hypothalamus region in the rat brain could be blocked by pretreatment with (+)McN5652, escitalopram and ADAM (2), which are all selective SERT ligands (at 2 mg/kg iv, 5 min pretreatment). Citalopram 124-136 solute carrier family 6 member 4 Rattus norvegicus 175-179 16448580-5 2007 In-vitro binding studies showed that R-citalopram attenuated the association rates of escitalopram and paroxetine to the 5-HT transporter, but had no effect on the association rates of fluoxetine, venlafaxine or sertraline. Citalopram 86-98 solute carrier family 6 member 4 Rattus norvegicus 121-137 16448580-12 2007 In conclusion, the present in-vitro and in-vivo studies show that R-citalopram counteracts the activity of escitalopram and paroxetine, but not fluoxetine, by acting at the allosteric binding site of the 5-HT transporter, either located in the dorsal raphe nucleus or post-synaptically in the ventral hippocampus. Citalopram 107-119 solute carrier family 6 member 4 Rattus norvegicus 204-220 16557463-0 2006 Inhibition of [3H]citalopram binding to the rat brain serotonin transporter by Amaryllidaceae alkaloids. Citalopram 18-28 solute carrier family 6 member 4 Rattus norvegicus 54-75